AGIO Agios Pharm

$24.57

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 11/21/2025

About Agios Pharm

Agios Pharmaceuticals, Inc., a biopharmaceutical company, is dedicated to drug discovery and development in the field of cellular metabolism and adjacent areas of biology. The company is headquartered in Cambridge, Massachusetts.

Website: https://www.agios.com

Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1439222
Address
88 SIDNEY STREET, CAMBRIDGE, MA, US
Valuation
Market Cap
$1.58B
P/E Ratio
2.38
PEG Ratio
0.00
Price to Book
1.03
Performance
EPS
$11.64
Dividend Yield
—
Profit Margin
1846.00%
ROE
57.30%
Technicals
50D MA
$31.23
200D MA
$41.04
52W High
$62.58
52W Low
$23.41
Fundamentals
Shares Outstanding
57M
Target Price
$53.32
Beta
0.83

AGIO EPS Estimates vs Actual

● Estimated
● Actual

AGIO News & Sentiment

Nov 20, 2025 • Zacks Commentary NEUTRAL
AGIO Stock Hits 52-Week Low on Mixed Sickle Cell Disease Study Results
Agios slides to a 52-week low after mixed phase III RISE UP data show a hemoglobin boost but no significant cut in pain crises.
Nov 20, 2025 • Benzinga SOMEWHAT-BULLISH
This Nasdaq Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Agios Pharmaceuticals ( NASDAQ:AGIO ) , Astera Labs ( NASDAQ:ALAB )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. BTIG analyst Ryan Zimmerman upgraded AVITA Medical Inc ( NASDAQ:RCEL ) from Sell to Neutral.
Nov 20, 2025 • Benzinga SOMEWHAT-BULLISH
Nvidia To Rally Around 72%? Here Are 10 Top Analyst Forecasts For Thursday - AECOM ( NYSE:ACM ) , Aclarion ( NASDAQ:ACON )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Piper Sandler raised Global-E Online Ltd ( NASDAQ:GLBE ) price target from $42 to $48.
Nov 19, 2025 • Motley Fool SOMEWHAT-BEARISH
Why Shares in Agios Pharmaceuticals Got Crushed Today
The company's pivotal Phase 3 trial hit one primary endpoint but missed another.
Nov 19, 2025 • Benzinga NEUTRAL
Crude Oil Falls Over 2%; Lowe's Shares Gain After Q3 Results - Agios Pharmaceuticals ( NASDAQ:AGIO ) , Carver Bancorp ( NASDAQ:CARV )
U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 0.2% on Wednesday. The Dow traded down 0.23% to 45,985.50 while the NASDAQ gained 0.19% to 22,475.54. The S&P 500 also rose, gaining, 0.08% to 6,622.69. Communication services shares rose by 0.8% on Wednesday.
Nov 19, 2025 • Benzinga NEUTRAL
Why Is Agios Pharmaceuticals Stock Sinking Today? - Agios Pharmaceuticals ( NASDAQ:AGIO )
Agios Pharmaceuticals Inc. ( NASDAQ:AGIO ) stock plunged on Wednesday after the company released topline results from RISE UP Phase 3 data for mitapivat in sickle cell disease. The trial met its primary endpoint of hemoglobin response, with mitapivat demonstrating a statistically significant ...
Sentiment Snapshot

Average Sentiment Score:

0.030
50 articles with scored sentiment

Overall Sentiment:

Neutral

AGIO Reported Earnings

Jul 31, 2025
Jun 30, 2025 (Pre market)
-0.18 Surprise
  • Reported EPS: $-1.93
  • Estimate: $-1.75
  • Whisper: —
  • Surprise %: -10.3%
May 01, 2025
Mar 31, 2025 (Pre market)
0.21 Surprise
  • Reported EPS: $-1.55
  • Estimate: $-1.76
  • Whisper: —
  • Surprise %: 11.9%
Feb 13, 2025
Dec 31, 2024 (Pre market)
-0.11 Surprise
  • Reported EPS: $-1.74
  • Estimate: $-1.63
  • Whisper: —
  • Surprise %: -6.8%
Oct 31, 2024
Sep 30, 2024 (Pre market)
-9.38 Surprise
  • Reported EPS: $-1.47
  • Estimate: $7.91
  • Whisper: —
  • Surprise %: -118.6%
Aug 01, 2024
Jun 30, 2024 (Pre market)
-0.09 Surprise
  • Reported EPS: $-1.69
  • Estimate: $-1.60
  • Whisper: —
  • Surprise %: -5.6%
May 02, 2024
Mar 31, 2024 (Pre market)
0.2 Surprise
  • Reported EPS: $-1.45
  • Estimate: $-1.65
  • Whisper: —
  • Surprise %: 12.1%
Feb 15, 2024
Dec 31, 2023 (Pre market)
-0.07 Surprise
  • Reported EPS: $-1.72
  • Estimate: $-1.65
  • Whisper: —
  • Surprise %: -4.2%
Nov 02, 2023
Sep 30, 2023 (Pre market)
0.06 Surprise
  • Reported EPS: $-1.64
  • Estimate: $-1.70
  • Whisper: —
  • Surprise %: 3.5%
Aug 03, 2023
Jun 30, 2023 (Pre market)
0.05 Surprise
  • Reported EPS: $-1.51
  • Estimate: $-1.56
  • Whisper: —
  • Surprise %: 3.2%

Financials